Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
The Journal of Antibiotics|November 1, 1977
The enhancement of beta-lactam antibiotic therapy by novobiocinA K Miller, E Celozzi, B A PelakThe Journal of Antibiotics|January 1, 1983
Quaternary heterocyclylamino beta-lactams. IV. Comparison of the in vivo antibacterial activities of L-640,876, mecillinam, cefoxitin and cefotaximeE Celozzi, B A Pelak, E O Stapley, et al.The Journal of Antibiotics|March 1, 1987
Quaternary heterocyclylamino beta-lactams. VI. In vitro and in vivo antibacterial properties of L-642,946 and L-652,813, a long acting cephemB A Pelak, E C Gilfillan, B Weissberger, et al.The Journal of Antibiotics|January 1, 1983
Quaternary heterocyclylamino beta-lactams. III. The mode of action of L-640,876 and the effect of NaCl on membrane permeability and bindingL R Koupal, B A Pelak, P J Cassidy, et al.The Journal of Antibiotics|May 1, 1989
L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosaM E Valiant, E C Gilfillan, H H Gadebusch, et al.The Journal of Antimicrobial Chemotherapy|September 1, 1979
Correlation of in vitro susceptibility with in vivo efficacy in mice for cefoxitin in comparison with cephalosporinsA K Miller, E Celozzi, B A Pelak, et al.Antimicrobial Agents and Chemotherapy|October 1, 1972
Cephamycins, a new family of beta-lactam antibiotics. 3. In vitro studiesA K Miller, E Celozzi, B A Pelak, et al.Journal of Chemotherapy (Florence, Italy)|July 18, 2002
Comparative in-vitro activities of ertapenem against aerobic bacterial pathogens isolated from patients with complicated intra-abdominal infectionsB A Pelak, G L Woods, H Teppler, et al.Journal of Medicinal Chemistry|January 1, 1991
(Acyloxy)alkyl carbamate prodrugs of norfloxacinJ Alexander, R A Fromtling, J A Bland, et al.Chemotherapy|January 1, 1984
Pharmacokinetic studies of norfloxacin in laboratory animalsE C Gilfillan, B A Pelak, J A Bland, et al.Pageof 3